Ketamine and psychedelics are getting a lot of hype, but they won't live up to it. This episode explains why, the main reason being that these treatments are just symptomatic, like tylenol or aspirin, and not disease-modifying. They thus don't have long-term benefits. They are like super-tylenol, which is not transformative for psychiatry.

---

Support this podcast: https://podcasters.spotify.com/pod/show/nassir-ghaemi/support

Get full access to The Psychiatry Letter at ghaemi.substack.com/subscribe